19 May 2013
Keywords: first, approvals, zeneca, glaxo, wellcome, migraine, products
Article | 17 March 1997
Migraine therapy has seen a phenomenal rate of growth over the last fewyears to become a billion dollar-plus market in 1996, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 March 1997
17 May 2013
© 2013 thepharmaletter.com